HEADER HYDROLASE 26-MAY-03 1UF8 TITLE CRYSTAL STRUCTURE OF C171A/V236A MUTANT OF N-CARBAMYL-D-AMINO ACID TITLE 2 AMIDOHYDROLASE COMPLEXED WITH N-CARBAMYL-D-PHENYLALANINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.5.1.77; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: AGROBACTERIUM SP.; SOURCE 3 ORGANISM_TAXID: 361; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PAD108 KEYWDS HYDROLASE, N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE, D-AMINO ACID, N- KEYWDS 2 CARBAMYL-D-PHENYLALANINE EXPDTA X-RAY DIFFRACTION AUTHOR H.HASHIMOTO,M.AOKI,T.SHIMIZU,T.NAKAI,H.MORIKAWA,Y.IKENAKA, AUTHOR 2 S.TAKAHASHI,M.SATO REVDAT 4 27-DEC-23 1UF8 1 REMARK REVDAT 3 10-NOV-21 1UF8 1 REMARK SEQADV REVDAT 2 24-FEB-09 1UF8 1 VERSN REVDAT 1 08-JUN-04 1UF8 0 JRNL AUTH H.HASHIMOTO,M.AOKI,T.SHIMIZU,T.NAKAI,H.MORIKAWA,Y.IKENAKA, JRNL AUTH 2 S.TAKAHASHI,M.SATO JRNL TITL CRYSTAL STRUCTURE OF C171A/V236A MUTANT OF JRNL TITL 2 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 61.09 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 59175 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4808 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 699 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1UF8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 28-MAY-03. REMARK 100 THE DEPOSITION ID IS D_1000005759. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59175 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 61.090 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.96 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.06 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 33.95300 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 69.24950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.95300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 69.24950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 67.90600 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH B 2212 O HOH B 2212 2655 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 116 4.00 -69.00 REMARK 500 HIS A 143 75.48 -153.87 REMARK 500 LEU A 144 41.36 -94.43 REMARK 500 PHE A 156 77.57 -113.80 REMARK 500 ASP A 162 -119.91 58.48 REMARK 500 ALA A 171 -111.10 40.03 REMARK 500 HIS A 284 -106.25 -136.02 REMARK 500 LYS B 116 3.88 -69.50 REMARK 500 HIS B 143 66.90 -151.81 REMARK 500 LEU B 144 41.16 -82.36 REMARK 500 ASP B 162 -116.40 57.95 REMARK 500 ALA B 171 -110.74 39.77 REMARK 500 HIS B 284 -105.83 -134.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ING A 999 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ING B 1999 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ERZ RELATED DB: PDB REMARK 900 RELATED ID: 1UF4 RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITHOUT LIGAND REMARK 900 RELATED ID: 1UF5 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH N-CARBAMYL-D-METHIONINE REMARK 900 RELATED ID: 1UF7 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH N-CARBAMYL-D-VALINE DBREF 1UF8 A 1 303 UNP P60327 DCAS_AGRSK 2 304 DBREF 1UF8 B 1 303 UNP P60327 DCAS_AGRSK 2 304 SEQADV 1UF8 ALA A 171 UNP P60327 CYS 172 ENGINEERED MUTATION SEQADV 1UF8 ALA A 236 UNP P60327 VAL 237 ENGINEERED MUTATION SEQADV 1UF8 ALA B 171 UNP P60327 CYS 172 ENGINEERED MUTATION SEQADV 1UF8 ALA B 236 UNP P60327 VAL 237 ENGINEERED MUTATION SEQRES 1 A 303 THR ARG GLN MET ILE LEU ALA VAL GLY GLN GLN GLY PRO SEQRES 2 A 303 ILE ALA ARG ALA GLU THR ARG GLU GLN VAL VAL VAL ARG SEQRES 3 A 303 LEU LEU ASP MET LEU THR LYS ALA ALA SER ARG GLY ALA SEQRES 4 A 303 ASN PHE ILE VAL PHE PRO GLU LEU ALA LEU THR THR PHE SEQRES 5 A 303 PHE PRO ARG TRP HIS PHE THR ASP GLU ALA GLU LEU ASP SEQRES 6 A 303 SER PHE TYR GLU THR GLU MET PRO GLY PRO VAL VAL ARG SEQRES 7 A 303 PRO LEU PHE GLU LYS ALA ALA GLU LEU GLY ILE GLY PHE SEQRES 8 A 303 ASN LEU GLY TYR ALA GLU LEU VAL VAL GLU GLY GLY VAL SEQRES 9 A 303 LYS ARG ARG PHE ASN THR SER ILE LEU VAL ASP LYS SER SEQRES 10 A 303 GLY LYS ILE VAL GLY LYS TYR ARG LYS ILE HIS LEU PRO SEQRES 11 A 303 GLY HIS LYS GLU TYR GLU ALA TYR ARG PRO PHE GLN HIS SEQRES 12 A 303 LEU GLU LYS ARG TYR PHE GLU PRO GLY ASP LEU GLY PHE SEQRES 13 A 303 PRO VAL TYR ASP VAL ASP ALA ALA LYS MET GLY MET PHE SEQRES 14 A 303 ILE ALA ASN ASP ARG ARG TRP PRO GLU ALA TRP ARG VAL SEQRES 15 A 303 MET GLY LEU ARG GLY ALA GLU ILE ILE CYS GLY GLY TYR SEQRES 16 A 303 ASN THR PRO THR HIS ASN PRO PRO VAL PRO GLN HIS ASP SEQRES 17 A 303 HIS LEU THR SER PHE HIS HIS LEU LEU SER MET GLN ALA SEQRES 18 A 303 GLY SER TYR GLN ASN GLY ALA TRP SER ALA ALA ALA GLY SEQRES 19 A 303 LYS ALA GLY MET GLU GLU ASN CYS MET LEU LEU GLY HIS SEQRES 20 A 303 SER CYS ILE VAL ALA PRO THR GLY GLU ILE VAL ALA LEU SEQRES 21 A 303 THR THR THR LEU GLU ASP GLU VAL ILE THR ALA ALA VAL SEQRES 22 A 303 ASP LEU ASP ARG CYS ARG GLU LEU ARG GLU HIS ILE PHE SEQRES 23 A 303 ASN PHE LYS GLN HIS ARG GLN PRO GLN HIS TYR GLY LEU SEQRES 24 A 303 ILE ALA GLU LEU SEQRES 1 B 303 THR ARG GLN MET ILE LEU ALA VAL GLY GLN GLN GLY PRO SEQRES 2 B 303 ILE ALA ARG ALA GLU THR ARG GLU GLN VAL VAL VAL ARG SEQRES 3 B 303 LEU LEU ASP MET LEU THR LYS ALA ALA SER ARG GLY ALA SEQRES 4 B 303 ASN PHE ILE VAL PHE PRO GLU LEU ALA LEU THR THR PHE SEQRES 5 B 303 PHE PRO ARG TRP HIS PHE THR ASP GLU ALA GLU LEU ASP SEQRES 6 B 303 SER PHE TYR GLU THR GLU MET PRO GLY PRO VAL VAL ARG SEQRES 7 B 303 PRO LEU PHE GLU LYS ALA ALA GLU LEU GLY ILE GLY PHE SEQRES 8 B 303 ASN LEU GLY TYR ALA GLU LEU VAL VAL GLU GLY GLY VAL SEQRES 9 B 303 LYS ARG ARG PHE ASN THR SER ILE LEU VAL ASP LYS SER SEQRES 10 B 303 GLY LYS ILE VAL GLY LYS TYR ARG LYS ILE HIS LEU PRO SEQRES 11 B 303 GLY HIS LYS GLU TYR GLU ALA TYR ARG PRO PHE GLN HIS SEQRES 12 B 303 LEU GLU LYS ARG TYR PHE GLU PRO GLY ASP LEU GLY PHE SEQRES 13 B 303 PRO VAL TYR ASP VAL ASP ALA ALA LYS MET GLY MET PHE SEQRES 14 B 303 ILE ALA ASN ASP ARG ARG TRP PRO GLU ALA TRP ARG VAL SEQRES 15 B 303 MET GLY LEU ARG GLY ALA GLU ILE ILE CYS GLY GLY TYR SEQRES 16 B 303 ASN THR PRO THR HIS ASN PRO PRO VAL PRO GLN HIS ASP SEQRES 17 B 303 HIS LEU THR SER PHE HIS HIS LEU LEU SER MET GLN ALA SEQRES 18 B 303 GLY SER TYR GLN ASN GLY ALA TRP SER ALA ALA ALA GLY SEQRES 19 B 303 LYS ALA GLY MET GLU GLU ASN CYS MET LEU LEU GLY HIS SEQRES 20 B 303 SER CYS ILE VAL ALA PRO THR GLY GLU ILE VAL ALA LEU SEQRES 21 B 303 THR THR THR LEU GLU ASP GLU VAL ILE THR ALA ALA VAL SEQRES 22 B 303 ASP LEU ASP ARG CYS ARG GLU LEU ARG GLU HIS ILE PHE SEQRES 23 B 303 ASN PHE LYS GLN HIS ARG GLN PRO GLN HIS TYR GLY LEU SEQRES 24 B 303 ILE ALA GLU LEU HET ING A 999 15 HET ING B1999 15 HETNAM ING D-[(AMINO)CARBONYL]PHENYLALANINE FORMUL 3 ING 2(C10 H12 N2 O3) FORMUL 5 HOH *699(H2 O) HELIX 1 1 THR A 19 ARG A 37 1 19 HELIX 2 2 PHE A 52 TRP A 56 5 5 HELIX 3 3 ASP A 60 SER A 66 1 7 HELIX 4 4 VAL A 77 GLY A 88 1 12 HELIX 5 5 LEU A 144 PHE A 149 1 6 HELIX 6 6 ILE A 170 ARG A 175 5 6 HELIX 7 7 TRP A 176 ARG A 186 1 11 HELIX 8 8 VAL A 204 HIS A 209 5 6 HELIX 9 9 LEU A 210 ASN A 226 1 17 HELIX 10 10 CYS A 278 GLU A 283 1 6 HELIX 11 11 ASN A 287 ARG A 292 1 6 HELIX 12 12 GLN A 293 GLU A 302 5 10 HELIX 13 13 THR B 19 ARG B 37 1 19 HELIX 14 14 PHE B 52 TRP B 56 5 5 HELIX 15 15 ASP B 60 SER B 66 1 7 HELIX 16 16 VAL B 77 GLY B 88 1 12 HELIX 17 17 LEU B 144 PHE B 149 1 6 HELIX 18 18 ILE B 170 ARG B 175 5 6 HELIX 19 19 TRP B 176 ARG B 186 1 11 HELIX 20 20 VAL B 204 HIS B 209 5 6 HELIX 21 21 LEU B 210 GLY B 227 1 18 HELIX 22 22 CYS B 278 GLU B 283 1 6 HELIX 23 23 ASN B 287 ARG B 292 1 6 HELIX 24 24 GLN B 293 HIS B 296 5 4 HELIX 25 25 TYR B 297 GLU B 302 1 6 SHEET 1 A 6 ILE A 120 ARG A 125 0 SHEET 2 A 6 VAL A 104 VAL A 114 -1 N LEU A 113 O VAL A 121 SHEET 3 A 6 GLY A 90 GLU A 101 -1 N GLU A 101 O VAL A 104 SHEET 4 A 6 PHE A 41 VAL A 43 1 N ILE A 42 O GLY A 90 SHEET 5 A 6 GLN A 3 GLN A 10 1 N ALA A 7 O VAL A 43 SHEET 6 A 6 GLU A 267 ASP A 274 -1 O VAL A 273 N MET A 4 SHEET 1 B 6 VAL A 158 VAL A 161 0 SHEET 2 B 6 ALA A 164 MET A 168 -1 O ALA A 164 N VAL A 161 SHEET 3 B 6 ILE A 190 TYR A 195 1 O ILE A 190 N GLY A 167 SHEET 4 B 6 TRP A 229 GLY A 234 1 O ALA A 233 N GLY A 193 SHEET 5 B 6 CYS A 249 VAL A 251 -1 O VAL A 251 N SER A 230 SHEET 6 B 6 ILE A 257 LEU A 260 -1 O VAL A 258 N ILE A 250 SHEET 1 C 2 GLY A 237 GLU A 239 0 SHEET 2 C 2 CYS A 242 LEU A 244 -1 O CYS A 242 N GLU A 239 SHEET 1 D 6 ILE B 120 ARG B 125 0 SHEET 2 D 6 VAL B 104 VAL B 114 -1 N LEU B 113 O VAL B 121 SHEET 3 D 6 GLY B 90 GLU B 101 -1 N VAL B 99 O ARG B 106 SHEET 4 D 6 PHE B 41 VAL B 43 1 N ILE B 42 O GLY B 90 SHEET 5 D 6 GLN B 3 GLN B 10 1 N ALA B 7 O VAL B 43 SHEET 6 D 6 GLU B 267 ASP B 274 -1 O VAL B 273 N MET B 4 SHEET 1 E 6 VAL B 158 VAL B 161 0 SHEET 2 E 6 ALA B 164 MET B 168 -1 O ALA B 164 N VAL B 161 SHEET 3 E 6 ILE B 190 TYR B 195 1 O ILE B 190 N GLY B 167 SHEET 4 E 6 TRP B 229 GLY B 234 1 O ALA B 233 N GLY B 193 SHEET 5 E 6 CYS B 249 VAL B 251 -1 O VAL B 251 N SER B 230 SHEET 6 E 6 ILE B 257 LEU B 260 -1 O VAL B 258 N ILE B 250 SHEET 1 F 2 GLY B 237 GLU B 239 0 SHEET 2 F 2 CYS B 242 LEU B 244 -1 O LEU B 244 N GLY B 237 CISPEP 1 MET A 72 PRO A 73 0 0.03 CISPEP 2 MET B 72 PRO B 73 0 -0.03 SITE 1 AC1 12 GLU A 46 LYS A 126 PRO A 130 HIS A 143 SITE 2 AC1 12 GLU A 145 ALA A 171 ASN A 172 ARG A 174 SITE 3 AC1 12 ARG A 175 ASN A 196 THR A 197 ASN A 201 SITE 1 AC2 13 ILE A 285 GLU B 46 LYS B 126 PRO B 130 SITE 2 AC2 13 HIS B 143 GLU B 145 ALA B 171 ASN B 172 SITE 3 AC2 13 ARG B 174 ARG B 175 ASN B 196 THR B 197 SITE 4 AC2 13 ASN B 201 CRYST1 67.906 138.499 68.065 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014726 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007220 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014692 0.00000